Acute alveolitis induced by hydroxyurea in a patient with myeloproliferative syndrome.
Hydroxyurea is increasingly being used to control myeloproliferative disorders, in part because of its relative lack of side effects. We present a case of life-threatening alveolitis in a patient treated with hydroxyurea for myeloproliferative syndrome. Absence of exposure to other drugs and the clinical course suggest that the alveolitis was induced by hydroxyurea.
Department of Internal Medicine I, University of Regensburg, Germany.
B
B
Hennemann
K J
KJ
Bross
A
A
Reichle
R
R
Andreesen
D000208:Acute Disease; D000368:Aged; D000542:Alveolitis, Extrinsic Allergic / Q000139:chemically induced*; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D009196:Myeloproliferative Disorders / Q000188:drug therapy*; D011014:Pneumonia / Q000139:chemically induced; D011650:Pulmonary Alveoli
D006918:Hydroxyurea